Molecular Partners AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.22 M | $10.55 M | 455.37% | 6.69% |
| BVF INC/IL | 02/14/2025 | 1.35 M | $6.46 M | 205.48% | 4.08% |
| UBS GROUP AG | 02/14/2025 | 6,872 | $32,628 | 31.00% | 0.02% |
| RHUMBLINE ADVISERS | 01/30/2025 | 269 | $1,283 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Molecular Partners AG institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Molecular Partners AG. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 2.22 M
BVF INC/IL: 1.35 M
UBS Group AG: 6,872
RHUMBLINE ADVISERS: 269
MORGAN STANLEY: 500
Marshall Wace North America L.P.: 0
10.79% of Molecular Partners AG stock is owned by institutional investors.
Institutional investors have bought a total of 3.58 M shares in the last 24 months. This purchase volume represents approximately $18.13 M in transactions.